Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01406860 · ClinicalTrials.gov registry record · NA
Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches
A NA study, sponsored by University of Iowa.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01406860 is a NA study that was terminated before completion, run by University of Iowa. The registered enrollment target is 19 participants.
The verdict
NCT01406860, a NA study, was terminated before completion, sponsored by University of Iowa.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if droperidol is equally as effective as metoclopramide for treatment of primary headaches in the Emergency Department.
Interventions
- DRUG Droperidol
- DRUG Metoclopramide + diphenhydramine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01406860
The ClinicalTrials.gov registry entry for NCT01406860 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Droperidol is the first listed.
NCT01406860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01406860 about?
NCT01406860 is a clinical study titled "Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches". The purpose of this study is to determine if droperidol is equally as effective as metoclopramide for treatment of primary headaches in the Emergency Department.
What is the current status of trial NCT01406860?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2011-07. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01406860?
The interventions under investigation include: Droperidol (DRUG), Metoclopramide + diphenhydramine (DRUG).
Who is sponsoring clinical trial NCT01406860?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.